Prevalence of Heavy Menstrual Bleeding in Female Population Living in Beijing
1 other identifier
observational
2,455
1 country
1
Brief Summary
The purpose of the study is to estimate the prevalence of heavy menstrual bleeding (HMB) in females aged between 18 and 50 years old living in Bejing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
November 27, 2014
CompletedFirst Posted
Study publicly available on registry
December 2, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedDecember 31, 2018
December 1, 2018
10 months
November 27, 2014
December 28, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of HMB
from date of inclusion until the end of the study currently planned (about 7 months)
Secondary Outcomes (2)
Prevalence of HMB in different subgroups
from date of inclusion until the end of the study currently planned (about 7 months)
Identify risk factors associated with HMB
from date of inclusion until the end of the study currently planned (about 7 months)
Study Arms (1)
females
females aged between 18 and 50 years old living in Beijing
Eligibility Criteria
residents of Beijing
You may qualify if:
- Females aged between 18 and 50 years (inclusive)
- Stay in Beijing for more than 6 months
- Signed ICF was obtained
You may not qualify if:
- Not achieve the menarche
- With the last menstruation more than one year ago
- Experienced amenorrhea, currently take hormone therapy to induce menstruation
- Had undergone a hysterectomy
- Currently breastfeeding a baby
- Being pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Peking Universitylead
- Bayercollaborator
Study Sites (1)
Peking University Health Science Center
Beijing, 100191, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Siyan Zhan, MD,PhD
Peking University Health Science Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 27, 2014
First Posted
December 2, 2014
Study Start
November 1, 2014
Primary Completion
September 1, 2015
Study Completion
December 1, 2016
Last Updated
December 31, 2018
Record last verified: 2018-12